DIABETIC GASTROINTESTINAL (GI) NEUROPATHY - EFFECT OF ALDOSE REDUCTASE INHIBITOR (ARI)

被引：0
|
作者：
KAVIN, H
JASPAN, J
GREEN, A
机构：
[1] MICHAEL REESE HOSP & MED CTR,DEPT MED,CHICAGO,IL 60616
[2] UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637
来源：
GASTROENTEROLOGY | 1986年 / 90卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1486 / 1486
页数：1
相关论文
共 50 条
  • [31] RECENT ADVANCES IN THE THERAPY OF DIABETIC PERIPHERAL NEUROPATHY BY MEANS OF AN ALDOSE REDUCTASE INHIBITOR
    GREENE, DA
    LATTIMER, SA
    [J]. AMERICAN JOURNAL OF MEDICINE, 1985, 79 (5A): : 13 - 17
  • [32] A CONTROLLED TRIAL OF SORBINIL, AN ALDOSE REDUCTASE INHIBITOR, IN CHRONIC PAINFUL DIABETIC NEUROPATHY
    YOUNG, RJ
    EWING, DJ
    CLARKE, BF
    [J]. DIABETES, 1983, 32 (10) : 938 - 942
  • [33] An aldose reductase inhibitor ameliorates diabetic autonomic neuropathy in type 2 diabetic subjects.
    Nakamura, J
    Nakayama, M
    Hamada, Y
    Chaya, S
    Kato, K
    Kasuya, Y
    Mizubayashi, R
    Miwa, K
    Yasuda, Y
    Kamiya, H
    Hotta, N
    [J]. DIABETOLOGIA, 1999, 42 : A293 - A293
  • [34] Nerve function and biochemistry in diabetic patients treated with ARI-509, a novel aldose reductase inhibitor
    Hohman, TC
    Bochenek, WJ
    Meng, X
    Neefe, L
    Beg, M
    [J]. DIABETOLOGIA, 1997, 40 : 2171 - 2171
  • [35] Effect of an aldose reductase inhibitor on esophageal dysfunction in diabetic patients
    Kinekawa, F
    Kubo, F
    Matsuda, K
    Fujita, Y
    Kobayashi, M
    Funakoshi, F
    Uchida, N
    Watanabe, S
    Tomita, T
    Uchida, Y
    Kuriyama, S
    [J]. HEPATO-GASTROENTEROLOGY, 2005, 52 (62) : 471 - 474
  • [36] Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy
    Greene, DA
    Arezzo, JC
    Brown, MB
    [J]. NEUROLOGY, 1999, 53 (03) : 580 - 591
  • [37] Diabetic neuropathy in ob/ob mice: Effect of aldose reductase inhibition
    Drel, Viktor R.
    Lyzogubov, Valeryi
    Marchand, Julie
    Li, Fei
    Obrosova, Irina G.
    [J]. DIABETES, 2006, 55 : A508 - A509
  • [38] THE EFFECT OF AN ALDOSE REDUCTASE INHIBITOR (EPALRESTAT) ON DIABETIC NEPHROPATHY IN RATS
    ITAGAKI, I
    SHIMIZU, K
    KAMANAKA, Y
    EBATA, K
    KIKKAWA, R
    HANEDA, M
    SHIGETA, Y
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1994, 25 (03) : 147 - 154
  • [39] INFLUENCE OF ALDOSE REDUCTASE INHIBITOR (ARI) ON NEUROGENIC VESICAL DYSFUNCTION IN DIABETES
    GREEN, A
    JASPAN, J
    KAVIN, H
    JAMES, D
    BARTKUS, C
    SCHOENBERG, H
    [J]. DIABETES, 1986, 35 : A102 - A102
  • [40] EFFECTS OF AN ALDOSE REDUCTASE INHIBITOR, SORBINIL, ON EXPERIMENTAL DIABETIC NEUROPATHY AND SUGAR CATARACTS IN RATS
    ISHIKO, J
    SUZUKI, M
    OHTSUKI, I
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 : P244 - P244
12345